The Effect of Murottal Quran on Fatigue Severity Scale and Shatri-Sinulingga Psychosomatic Test Scores in Patients With Human Immunodeficiency Virus Experiencing Psychosomatic Symptoms and Fatigue: A Randomized Controlled Trial

This randomized controlled trial evaluates the effect of Quranic recitation (murottal) on psychosomatic symptoms and fatigue in adults living with HIV who have psychosomatic symptoms and fatigue. Participants are randomly assigned to either the intervention group, which receives Quranic recitation for approximately 15 minutes, three times per week for 30 days, or the control group. Psychosomatic symptoms and fatigue are assessed before and after the intervention using the Shatri-Sinulingga Psychosomatic Test (SSPT) and Fatigue Severity Scale (FSS), respectively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psychosomatic Symptoms Fatigue Fatigue Symptom Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

RSUPN Dr. Cipto Mangunkusumo

Jakarta, DKI Jakarta, 10430, Indonesia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults aged ≥18 years. Diagnosed with human immunodeficiency virus (HIV) infection. Muslim. HIV clinical stage 1-2. Undetectable HIV viral load. Shatri-Sinulingga Psychosomatic Test (SSPT) score ≥2. Fatigue Severity Scale (FSS) score ≥36. Willing to participate in the study and provide informed consent.

Exclusion criteria

Severe hearing impairment or inability to follow the intervention procedure. Psychotic disorder or depressive disorder requiring psychiatric medication. Pregnancy. Active opportunistic infection. Refusal to participate in the study.

Treatment and study plan

Quranic Recitation (Murottal)

Behavioral

Participants receive Quranic recitation (murottal) for approximately 15 minutes, three times per week for 30 days (12 sessions).

Primary outcomes

Change in Shatri-Sinulingga Psychosomatic Test (SSPT) Score

Time frame: Baseline to 30 days after randomization
Change in Fatigue Severity Scale (FSS) Score

Time frame: Baseline to 30 days after randomization

Sponsors and collaborators

Lead sponsor

Universitas Indonesia

Other

Registry information

Acronym: MUQ-HIV

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Sep 22, 2026
Registry last updated: Sep 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not yet recruiting